Skip to main content

Table 3 Mean (and 95%CI) K10, PHQ-9, and EQ-5D scores at Baseline, 3-months and 6-months for full sample

From: Effectiveness of Wellbeing Intervention for Chronic Kidney Disease (WICKD): results of a randomised controlled trial

Measure

Timepoint

ISS

HepB/DSS

TAU/DSS

n

Mean (95% CI)

n

Mean (95% CI)

n

Mean (95% CI)

K10

Baseline

62

21.4 (19.3–23.5)

61

23.6 (21.5–25.7)

33

22.3 (19.5–25.2)

3-months

58

22.1 (19.9–24.2)

59

21.1 (18.9–23.2)

30

22.7 (19.8–25.7)

6-months

56

20.4 (18.3–22.6)

57

20.0 (17.8–22.1)

30

21.5 (18.6–24.5)

PHQ-9

Baseline

62

8.4 (7.1–9.7)

61

9.1 (7.7–10.4)

33

7.9 (6.1–9.7)

3-months

58

8.2 (6.8–9.6)

59

7.5 (6.1–8.9)

30

8.8 (6.9–10.6)

6-months

56

7.7 (6.3–9.0)

57

7.6 (6.3–9.0)

30

8.2 (6.3–10.1)

EQ-5D

Baseline

62

0.78 (0.72–0.84)

31

0.79 (0.72–0.85)

33

0.83 (0.74–0.91)

3 months

58

0.77 (0.70–0.83)

59

0.84 (0.78–0.90)

30

0.79 (0.71–0.88)

6 months

56

0.82 (0.75–0.88)

57

0.83 (0.76–0.89)

30

0.82 (0.73–0.91)